# Genomic Insights into Chromosomal Colistin Resistance and Virulence–Resistance Convergence in MDR/XDR Klebsiella pneumoniae from Tertiary Hospitals in Peshawar, Pakistan

**Authors:** Aiman Waheed, Sumera Afzal Khan, Sajjad Ahmad, Jody E. Phelan, Gulab Fatima Rani, Susana Campino, Taj Ali Khan, Taane G. Clark

PMC · DOI: 10.3390/pathogens15020218 · 2026-02-14

## TL;DR

This study examines drug-resistant and highly virulent Klebsiella pneumoniae bacteria in Pakistan, revealing genetic factors that contribute to resistance and virulence.

## Contribution

The study identifies chromosomal mutations and plasmid-mediated resistance genes in MDR/XDR K. pneumoniae isolates from Pakistan, highlighting virulence-resistance convergence.

## Key findings

- 19 (34.5%) of 55 K. pneumoniae isolates were MDR and 10 (18.2%) were XDR.
- Genomic analysis revealed chromosomal mutations and plasmid-borne resistance genes contributing to colistin resistance and virulence.
- One isolate showed an expanded virulence gene repertoire, indicating hypervirulence in an MDR background.

## Abstract

Background: Klebsiella pneumoniae is a World Health Organization-listed critical priority pathogen and a major cause of healthcare-associated infections, driven by the global emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) lineages and their alarming convergence with hypervirulence. Methods: In this study, 152 clinical specimens, including urine, blood, pus, wound swabs, and respiratory samples, were collected from tertiary care hospitals in Peshawar, Pakistan. Standard microbiological and biochemical methods identified 55 K. pneumoniae isolates. Antimicrobial susceptibility testing (AST) was performed using the Kirby–Bauer disk diffusion and broth microdilution methods, with results interpreted according to Clinical and Laboratory Standards Institute (CLSI) guidelines. MDR and XDR phenotypes were defined based on European Centre for Disease Prevention and Control (ECDC) criteria. Whole-genome sequencing (WGS) was conducted on 16 phenotypically confirmed MDR/XDR isolates, followed by comprehensive bioinformatic analyses to characterize sequence types (STs), acquired antimicrobial resistance genes, resistance-associated chromosomal mutations, virulence determinants, plasmid replicons, and phylogenetic relationships. Results: Among 55 confirmed K. pneumoniae isolates, 19 (34.5%) were classified as MDR and 10 (18.2%) as XDR. WGS revealed substantial genomic heterogeneity, identifying 11 distinct STs, with ST39 being the most prevalent. Resistance to multiple antibiotic classes was mediated by the combined presence of plasmid-borne carbapenemases and extended-spectrum β-lactamases, alongside chromosomal mutations affecting outer membrane porins (OmpK35/OmpK36), fluoroquinolone targets (gyrA/parC), efflux regulation (ramR, marR), and lipid A modification pathways associated with colistin resistance (mgrB, pmrA/pmrB, arnC, crrB). IncF-family plasmids predominated and frequently co-occurred with additional resistance-associated replicons. Notably, one isolate exhibited an expanded virulence gene repertoire, including multiple siderophore systems and a complete type II secretion system, consistent with a hypervirulence-associated genomic profile. Phylogenetic analyses demonstrated close relatedness to international lineages from Asia, the Middle East, and Europe, indicating regional and transnational dissemination. Conclusions: This study highlights the complex interplay between plasmid-mediated gene acquisition and chromosomal adaptive mutations driving MDR and XDR phenotypes in K. pneumoniae circulating in Peshawar, Pakistan. The identification of hypervirulence-associated genetic features within an MDR background underscores the growing threat posed by convergent lineages and emphasizes the need for sustained WGS-based surveillance to inform infection control and antimicrobial stewardship strategies.

## Linked entities

- **Genes:** ompK35 (porin OmpK35) [NCBI Gene 69756156], ompK36 (porin OmpK36) [NCBI Gene 57503781], GYRA (DNA GYRASE A) [NCBI Gene 820238], CCL18 (C-C motif chemokine ligand 18) [NCBI Gene 6362], ramR (two-component system response regulator RamR) [NCBI Gene 91300543], marR (transcriptional repressor) [NCBI Gene 917336], mgrB (PhoQ kinase inhibitor) [NCBI Gene 946351], pmrA (two-component regulator system response regulator PmrA) [NCBI Gene 881834], pmrB (two-component regulator system signal sensor kinase PmrB) [NCBI Gene 881841], arnC (undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase) [NCBI Gene 878472]
- **Species:** Klebsiella pneumoniae (taxon 573)

## Full-text entities

- **Diseases:** K. pneumoniae (MESH:D011014), Klebsiella pneumoniae (MESH:D007710), AMR (MESH:D060467), injury to (MESH:D014947), respiratory infection (MESH:D012141), skin and soft tissue infections (MESH:D018461), abscesses (MESH:D000038), critically ill (MESH:D016638), MDR (MESH:D018088), intra-abdominal sepsis (MESH:D000082122), bloodstream infection (MESH:D018805), Gram-negative bacterial infection (MESH:D016905), Enterobacterales infections (MESH:D007239), XDR (MESH:D054908), bacteremia (MESH:D016470), wound infections (MESH:D014946), Urinary tract infections (MESH:D014552)
- **Chemicals:** Gentamicin (MESH:D005839), lipid A (MESH:D008050), carbapenem (MESH:D015780), CAZ (MESH:D002442), iron (MESH:D007501), tetracyclines (MESH:D013754), Cefepime (MESH:D000077723), Meropenem (MESH:D000077731), lactose (MESH:D007785), polysaccharide (MESH:D011134), Amoxicillin-Clavulanic acid (MESH:D019980), Ciprofloxacin (MESH:D002939), Tigecycline (MESH:D000078304), Aminoglycoside (MESH:D000617), glycylcyclines (MESH:C087533), FEP (MESH:D011138), beta-lactam (MESH:D047090), indole (MESH:C030374), AMP (MESH:D000249), Ampicillin (MESH:D000667), citrate (MESH:D019343), cefazolin (MESH:D002437), methyl red (MESH:C008492), agarose (MESH:D012685), cephalosporins (MESH:D002511), Piperacillin-Tazobactam (MESH:D000077725), Fluoroquinolone (MESH:D024841), Amikacin (MESH:D000583), quinolone (MESH:D015363), Cefoperazone-Sulbactam (-), Cefotaxime (MESH:D002439), Ceftazidime-Avibactam (MESH:C000595613), glycerol (MESH:D005990), Tetracycline (MESH:D013752)
- **Species:** Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** K71L, H349R, V375A, S21A, T290A, N212T, S681A, Y183W, S83I, V178P, A101S, 80  C, E350Q, M66I, N276D, L213M, C for 18-24, I127V, D350N, N221H, K49Q, L307I, N304S, S253G, E247K, Q287K, V237I, S357N, L184DEL, G259T, I141T, T258S, D344E, V192G, T192G, S80I, R234F, G50A, E81V, M184V, N19S, T47A, Y108S, G129D, Y201F, S346D, S30T, A249T, F862I, D306N, I315L, E644V, K325R

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943686/full.md

---
Source: https://tomesphere.com/paper/PMC12943686